nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—CYP2C9—brain cancer	0.628	1	CbGaD
Sulfamethoxazole—CYP3A4—Temozolomide—brain cancer	0.0497	0.291	CbGbCtD
Sulfamethoxazole—PTGS1—Etoposide—brain cancer	0.0437	0.255	CbGbCtD
Sulfamethoxazole—CYP3A4—Lomustine—brain cancer	0.0423	0.247	CbGbCtD
Sulfamethoxazole—CYP2C8—Etoposide—brain cancer	0.0252	0.147	CbGbCtD
Sulfamethoxazole—NAT2—pineal body—brain cancer	0.0123	0.286	CbGeAlD
Sulfamethoxazole—NAT1—pineal body—brain cancer	0.0112	0.26	CbGeAlD
Sulfamethoxazole—CYP3A4—Etoposide—brain cancer	0.0102	0.0597	CbGbCtD
Sulfamethoxazole—Nephrotoxicity—Lomustine—brain cancer	0.00682	0.0501	CcSEcCtD
Sulfamethoxazole—Lung infiltration—Lomustine—brain cancer	0.00463	0.0339	CcSEcCtD
Sulfamethoxazole—Anaemia megaloblastic—Hydroxyurea—brain cancer	0.00452	0.0332	CcSEcCtD
Sulfamethoxazole—Nephropathy toxic—Lomustine—brain cancer	0.00378	0.0277	CcSEcCtD
Sulfamethoxazole—Nephrotoxicity—Carmustine—brain cancer	0.00271	0.0199	CcSEcCtD
Sulfamethoxazole—NAT1—pituitary gland—brain cancer	0.00253	0.0585	CbGeAlD
Sulfamethoxazole—NAT1—medulla oblongata—brain cancer	0.00244	0.0565	CbGeAlD
Sulfamethoxazole—Lung infiltration—Hydroxyurea—brain cancer	0.00227	0.0167	CcSEcCtD
Sulfamethoxazole—NAT2—endocrine gland—brain cancer	0.00216	0.0499	CbGeAlD
Sulfamethoxazole—NAT1—endocrine gland—brain cancer	0.00196	0.0454	CbGeAlD
Sulfamethoxazole—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00192	0.0141	CcSEcCtD
Sulfamethoxazole—Lung infiltration—Carmustine—brain cancer	0.00184	0.0135	CcSEcCtD
Sulfamethoxazole—Eruption—Hydroxyurea—brain cancer	0.00173	0.0127	CcSEcCtD
Sulfamethoxazole—Digestion impaired—Hydroxyurea—brain cancer	0.00159	0.0117	CcSEcCtD
Sulfamethoxazole—Bone marrow depression—Hydroxyurea—brain cancer	0.00158	0.0116	CcSEcCtD
Sulfamethoxazole—Nephropathy toxic—Carmustine—brain cancer	0.0015	0.011	CcSEcCtD
Sulfamethoxazole—Ataxia—Lomustine—brain cancer	0.00148	0.0109	CcSEcCtD
Sulfamethoxazole—NAT1—brain—brain cancer	0.0014	0.0324	CbGeAlD
Sulfamethoxazole—Pancytopenia—Lomustine—brain cancer	0.00129	0.00948	CcSEcCtD
Sulfamethoxazole—PTGS1—ganglion—brain cancer	0.00126	0.0291	CbGeAlD
Sulfamethoxazole—Digestion impaired—Temozolomide—brain cancer	0.00125	0.00914	CcSEcCtD
Sulfamethoxazole—Renal failure—Lomustine—brain cancer	0.00119	0.00875	CcSEcCtD
Sulfamethoxazole—Stomatitis—Lomustine—brain cancer	0.00118	0.00868	CcSEcCtD
Sulfamethoxazole—Apathy—Temozolomide—brain cancer	0.00117	0.00855	CcSEcCtD
Sulfamethoxazole—UGT1A9—endocrine gland—brain cancer	0.00116	0.0269	CbGeAlD
Sulfamethoxazole—Nephropathy toxic—Etoposide—brain cancer	0.00116	0.00851	CcSEcCtD
Sulfamethoxazole—Flat affect—Temozolomide—brain cancer	0.00116	0.00848	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Procarbazine—brain cancer	0.00114	0.00835	CcSEcCtD
Sulfamethoxazole—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00113	0.00827	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Procarbazine—brain cancer	0.00112	0.0082	CcSEcCtD
Sulfamethoxazole—Haemolytic anaemia—Procarbazine—brain cancer	0.00111	0.00813	CcSEcCtD
Sulfamethoxazole—PTGS1—endothelium—brain cancer	0.00108	0.0251	CbGeAlD
Sulfamethoxazole—Sulfamoxole—CYP2C9—brain cancer	0.00107	0.162	CrCbGaD
Sulfamethoxazole—Sulfadimethoxine—CYP2C9—brain cancer	0.00107	0.162	CrCbGaD
Sulfamethoxazole—Purpura—Procarbazine—brain cancer	0.00104	0.00761	CcSEcCtD
Sulfamethoxazole—NAT1—Biological oxidations—CYP2C9—brain cancer	0.00103	0.0698	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00101	0.0688	CbGpPWpGaD
Sulfamethoxazole—PTGS1—blood vessel—brain cancer	0.001	0.0231	CbGeAlD
Sulfamethoxazole—Sulfapyridine—CYP2C9—brain cancer	0.000987	0.148	CrCbGaD
Sulfamethoxazole—Ataxia—Procarbazine—brain cancer	0.00094	0.0069	CcSEcCtD
Sulfamethoxazole—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000909	0.0618	CbGpPWpGaD
Sulfamethoxazole—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.0009	0.00661	CcSEcCtD
Sulfamethoxazole—Hepatic enzyme increased—Temozolomide—brain cancer	0.00088	0.00646	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Procarbazine—brain cancer	0.000855	0.00628	CcSEcCtD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.000851	0.0579	CbGpPWpGaD
Sulfamethoxazole—Leukopenia—Lomustine—brain cancer	0.000849	0.00623	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Procarbazine—brain cancer	0.000847	0.00622	CcSEcCtD
Sulfamethoxazole—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000828	0.0562	CbGpPWpGaD
Sulfamethoxazole—Pancytopenia—Procarbazine—brain cancer	0.00082	0.00602	CcSEcCtD
Sulfamethoxazole—Sulfamethizole—CYP2C9—brain cancer	0.000814	0.122	CrCbGaD
Sulfamethoxazole—Sulfisoxazole—CYP2C9—brain cancer	0.000814	0.122	CrCbGaD
Sulfamethoxazole—Photosensitivity reaction—Procarbazine—brain cancer	0.000789	0.00579	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Temozolomide—brain cancer	0.000782	0.00574	CcSEcCtD
Sulfamethoxazole—Pneumonia—Procarbazine—brain cancer	0.000775	0.00569	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Lomustine—brain cancer	0.000758	0.00556	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Procarbazine—brain cancer	0.000755	0.00554	CcSEcCtD
Sulfamethoxazole—Stomatitis—Procarbazine—brain cancer	0.000751	0.00551	CcSEcCtD
Sulfamethoxazole—Anorexia—Lomustine—brain cancer	0.000738	0.00541	CcSEcCtD
Sulfamethoxazole—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.000705	0.0479	CbGpPWpGaD
Sulfamethoxazole—Body temperature increased—Carboplatin—brain cancer	0.000699	0.00513	CcSEcCtD
Sulfamethoxazole—Hallucination—Procarbazine—brain cancer	0.000688	0.00505	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Temozolomide—brain cancer	0.000676	0.00496	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Lomustine—brain cancer	0.000673	0.00494	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Hydroxyurea—brain cancer	0.000656	0.00481	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Temozolomide—brain cancer	0.00064	0.0047	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Hydroxyurea—brain cancer	0.000635	0.00466	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Carmustine—brain cancer	0.000628	0.00461	CcSEcCtD
Sulfamethoxazole—Purpura—Temozolomide—brain cancer	0.000627	0.0046	CcSEcCtD
Sulfamethoxazole—Neutropenia—Hydroxyurea—brain cancer	0.000625	0.00459	CcSEcCtD
Sulfamethoxazole—Chills—Procarbazine—brain cancer	0.00062	0.00455	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Lomustine—brain cancer	0.000612	0.00449	CcSEcCtD
Sulfamethoxazole—Infestation—Hydroxyurea—brain cancer	0.000596	0.00438	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Hydroxyurea—brain cancer	0.000596	0.00438	CcSEcCtD
Sulfamethoxazole—Tension—Procarbazine—brain cancer	0.000591	0.00434	CcSEcCtD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00059	0.0401	CbGpPWpGaD
Sulfamethoxazole—Sulfadiazine—CYP2C9—brain cancer	0.00059	0.0887	CrCbGaD
Sulfamethoxazole—Ataxia—Carmustine—brain cancer	0.000588	0.00432	CcSEcCtD
Sulfamethoxazole—Nervousness—Procarbazine—brain cancer	0.000585	0.00429	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000584	0.00429	CcSEcCtD
Sulfamethoxazole—Stomatitis—Hydroxyurea—brain cancer	0.000581	0.00426	CcSEcCtD
Sulfamethoxazole—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00057	0.0387	CbGpPWpGaD
Sulfamethoxazole—Ataxia—Temozolomide—brain cancer	0.000568	0.00417	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000564	0.00414	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000544	0.00399	CcSEcCtD
Sulfamethoxazole—Sulfaphenazole—CYP2C9—brain cancer	0.00054	0.0812	CrCbGaD
Sulfamethoxazole—Leukopenia—Procarbazine—brain cancer	0.000539	0.00395	CcSEcCtD
Sulfamethoxazole—Hallucination—Hydroxyurea—brain cancer	0.000532	0.00391	CcSEcCtD
Sulfamethoxazole—Cough—Procarbazine—brain cancer	0.000525	0.00386	CcSEcCtD
Sulfamethoxazole—Convulsion—Procarbazine—brain cancer	0.000522	0.00383	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Carmustine—brain cancer	0.000513	0.00377	CcSEcCtD
Sulfamethoxazole—Arthralgia—Procarbazine—brain cancer	0.000512	0.00376	CcSEcCtD
Sulfamethoxazole—Myalgia—Procarbazine—brain cancer	0.000512	0.00376	CcSEcCtD
Sulfamethoxazole—Neutropenia—Carmustine—brain cancer	0.000505	0.00371	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Temozolomide—brain cancer	0.000496	0.00364	CcSEcCtD
Sulfamethoxazole—Vomiting—Lomustine—brain cancer	0.000492	0.00361	CcSEcCtD
Sulfamethoxazole—Neutropenia—Temozolomide—brain cancer	0.000488	0.00358	CcSEcCtD
Sulfamethoxazole—CYP2C8—pituitary gland—brain cancer	0.000487	0.0113	CbGeAlD
Sulfamethoxazole—PTGS1—telencephalon—brain cancer	0.000485	0.0112	CbGeAlD
Sulfamethoxazole—Pneumonia—Carmustine—brain cancer	0.000485	0.00356	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Procarbazine—brain cancer	0.000481	0.00353	CcSEcCtD
Sulfamethoxazole—Depression—Carmustine—brain cancer	0.000481	0.00353	CcSEcCtD
Sulfamethoxazole—Chills—Hydroxyurea—brain cancer	0.00048	0.00352	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Temozolomide—brain cancer	0.000477	0.0035	CcSEcCtD
Sulfamethoxazole—Renal failure—Carmustine—brain cancer	0.000474	0.00348	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Carmustine—brain cancer	0.000472	0.00347	CcSEcCtD
Sulfamethoxazole—Stomatitis—Carmustine—brain cancer	0.00047	0.00345	CcSEcCtD
Sulfamethoxazole—Pneumonia—Temozolomide—brain cancer	0.000468	0.00344	CcSEcCtD
Sulfamethoxazole—Anorexia—Procarbazine—brain cancer	0.000468	0.00344	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Temozolomide—brain cancer	0.000466	0.00342	CcSEcCtD
Sulfamethoxazole—Infestation—Temozolomide—brain cancer	0.000466	0.00342	CcSEcCtD
Sulfamethoxazole—Depression—Temozolomide—brain cancer	0.000464	0.00341	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000462	0.00339	CcSEcCtD
Sulfamethoxazole—Nausea—Lomustine—brain cancer	0.00046	0.00337	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Temozolomide—brain cancer	0.000457	0.00335	CcSEcCtD
Sulfamethoxazole—Stomatitis—Temozolomide—brain cancer	0.000454	0.00333	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000448	0.00328	CcSEcCtD
Sulfamethoxazole—Insomnia—Procarbazine—brain cancer	0.000444	0.00326	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Temozolomide—brain cancer	0.00044	0.00323	CcSEcCtD
Sulfamethoxazole—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000437	0.0297	CbGpPWpGaD
Sulfamethoxazole—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000435	0.0032	CcSEcCtD
Sulfamethoxazole—Hallucination—Carmustine—brain cancer	0.00043	0.00316	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Procarbazine—brain cancer	0.000427	0.00313	CcSEcCtD
Sulfamethoxazole—NAT2—Biological oxidations—CYP2C9—brain cancer	0.000426	0.029	CbGpPWpGaD
Sulfamethoxazole—Connective tissue disorder—Carmustine—brain cancer	0.000425	0.00312	CcSEcCtD
Sulfamethoxazole—Fatigue—Procarbazine—brain cancer	0.000424	0.00311	CcSEcCtD
Sulfamethoxazole—NAT2—Metapathway biotransformation—CYP2C9—brain cancer	0.000421	0.0286	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00042	0.0286	CbGpPWpGaD
Sulfamethoxazole—Hepatitis—Temozolomide—brain cancer	0.000418	0.00307	CcSEcCtD
Sulfamethoxazole—Leukopenia—Hydroxyurea—brain cancer	0.000417	0.00306	CcSEcCtD
Sulfamethoxazole—Hallucination—Temozolomide—brain cancer	0.000416	0.00305	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Temozolomide—brain cancer	0.000413	0.00303	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Temozolomide—brain cancer	0.000411	0.00302	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Temozolomide—brain cancer	0.00041	0.00301	CcSEcCtD
Sulfamethoxazole—Eye disorder—Carmustine—brain cancer	0.000404	0.00297	CcSEcCtD
Sulfamethoxazole—Convulsion—Hydroxyurea—brain cancer	0.000404	0.00296	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Procarbazine—brain cancer	0.000402	0.00295	CcSEcCtD
Sulfamethoxazole—Sulfanilamide—CYP2C9—brain cancer	0.000401	0.0603	CrCbGaD
Sulfamethoxazole—Pancytopenia—Etoposide—brain cancer	0.000397	0.00291	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Temozolomide—brain cancer	0.000395	0.0029	CcSEcCtD
Sulfamethoxazole—PTGS1—pituitary gland—brain cancer	0.000395	0.00914	CbGeAlD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000394	0.00289	CcSEcCtD
Sulfamethoxazole—Neutropenia—Etoposide—brain cancer	0.000391	0.00287	CcSEcCtD
Sulfamethoxazole—Eye disorder—Temozolomide—brain cancer	0.000391	0.00287	CcSEcCtD
Sulfamethoxazole—Urticaria—Procarbazine—brain cancer	0.00039	0.00286	CcSEcCtD
Sulfamethoxazole—Tinnitus—Temozolomide—brain cancer	0.00039	0.00286	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Procarbazine—brain cancer	0.000388	0.00285	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Procarbazine—brain cancer	0.000388	0.00285	CcSEcCtD
Sulfamethoxazole—ALB—brain—brain cancer	0.000384	0.00889	CbGeAlD
Sulfamethoxazole—Mental disorder—Carmustine—brain cancer	0.000379	0.00278	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Temozolomide—brain cancer	0.000378	0.00277	CcSEcCtD
Sulfamethoxazole—CYP2C8—endocrine gland—brain cancer	0.000378	0.00873	CbGeAlD
Sulfamethoxazole—Mediastinal disorder—Temozolomide—brain cancer	0.000377	0.00277	CcSEcCtD
Sulfamethoxazole—Malnutrition—Carmustine—brain cancer	0.000377	0.00276	CcSEcCtD
Sulfamethoxazole—Chills—Temozolomide—brain cancer	0.000375	0.00275	CcSEcCtD
Sulfamethoxazole—Pneumonia—Etoposide—brain cancer	0.000375	0.00275	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Hydroxyurea—brain cancer	0.000373	0.00274	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Etoposide—brain cancer	0.000373	0.00274	CcSEcCtD
Sulfamethoxazole—Infestation—Etoposide—brain cancer	0.000373	0.00274	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Hydroxyurea—brain cancer	0.000372	0.00273	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000369	0.00271	CcSEcCtD
Sulfamethoxazole—Skin disorder—Hydroxyurea—brain cancer	0.000369	0.00271	CcSEcCtD
Sulfamethoxazole—Renal failure—Etoposide—brain cancer	0.000366	0.00269	CcSEcCtD
Sulfamethoxazole—Mental disorder—Temozolomide—brain cancer	0.000366	0.00269	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Etoposide—brain cancer	0.000365	0.00268	CcSEcCtD
Sulfamethoxazole—Malnutrition—Temozolomide—brain cancer	0.000364	0.00267	CcSEcCtD
Sulfamethoxazole—Stomatitis—Etoposide—brain cancer	0.000363	0.00267	CcSEcCtD
Sulfamethoxazole—Anorexia—Hydroxyurea—brain cancer	0.000362	0.00266	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Procarbazine—brain cancer	0.000362	0.00266	CcSEcCtD
Sulfamethoxazole—Dapsone—CYP2C9—brain cancer	0.000357	0.0538	CrCbGaD
Sulfamethoxazole—Asthenia—Procarbazine—brain cancer	0.000352	0.00259	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Etoposide—brain cancer	0.000352	0.00259	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Etoposide—brain cancer	0.000348	0.00255	CcSEcCtD
Sulfamethoxazole—Pruritus—Procarbazine—brain cancer	0.000348	0.00255	CcSEcCtD
Sulfamethoxazole—PTGS1—spinal cord—brain cancer	0.00034	0.00786	CbGeAlD
Sulfamethoxazole—Dyspnoea—Hydroxyurea—brain cancer	0.000339	0.00249	CcSEcCtD
Sulfamethoxazole—Leukopenia—Carmustine—brain cancer	0.000337	0.00247	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Procarbazine—brain cancer	0.000336	0.00247	CcSEcCtD
Sulfamethoxazole—CYP2C9—endocrine gland—brain cancer	0.000335	0.00775	CbGeAlD
Sulfamethoxazole—Dyspepsia—Hydroxyurea—brain cancer	0.000335	0.00246	CcSEcCtD
Sulfamethoxazole—Angioedema—Temozolomide—brain cancer	0.000333	0.00244	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Hydroxyurea—brain cancer	0.000331	0.00243	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Etoposide—brain cancer	0.00033	0.00242	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000328	0.00241	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Etoposide—brain cancer	0.000328	0.00241	CcSEcCtD
Sulfamethoxazole—Fatigue—Hydroxyurea—brain cancer	0.000328	0.00241	CcSEcCtD
Sulfamethoxazole—Vertigo—Temozolomide—brain cancer	0.000327	0.0024	CcSEcCtD
Sulfamethoxazole—Convulsion—Carmustine—brain cancer	0.000326	0.00239	CcSEcCtD
Sulfamethoxazole—Leukopenia—Temozolomide—brain cancer	0.000326	0.00239	CcSEcCtD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000325	0.0221	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Procarbazine—brain cancer	0.000325	0.00238	CcSEcCtD
Sulfamethoxazole—Myalgia—Carmustine—brain cancer	0.000321	0.00235	CcSEcCtD
Sulfamethoxazole—Cough—Temozolomide—brain cancer	0.000318	0.00233	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Etoposide—brain cancer	0.000316	0.00232	CcSEcCtD
Sulfamethoxazole—Convulsion—Temozolomide—brain cancer	0.000315	0.00231	CcSEcCtD
Sulfamethoxazole—Eye disorder—Etoposide—brain cancer	0.000313	0.00229	CcSEcCtD
Sulfamethoxazole—Vomiting—Procarbazine—brain cancer	0.000312	0.00229	CcSEcCtD
Sulfamethoxazole—Myalgia—Temozolomide—brain cancer	0.00031	0.00227	CcSEcCtD
Sulfamethoxazole—Arthralgia—Temozolomide—brain cancer	0.00031	0.00227	CcSEcCtD
Sulfamethoxazole—Rash—Procarbazine—brain cancer	0.00031	0.00227	CcSEcCtD
Sulfamethoxazole—Dermatitis—Procarbazine—brain cancer	0.000309	0.00227	CcSEcCtD
Sulfamethoxazole—Headache—Procarbazine—brain cancer	0.000308	0.00226	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000308	0.00226	CcSEcCtD
Sulfamethoxazole—PTGS1—endocrine gland—brain cancer	0.000306	0.00708	CbGeAlD
Sulfamethoxazole—PTGS1—head—brain cancer	0.000302	0.00699	CbGeAlD
Sulfamethoxazole—Immune system disorder—Etoposide—brain cancer	0.000302	0.00222	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Etoposide—brain cancer	0.000302	0.00221	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Carmustine—brain cancer	0.000301	0.00221	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Hydroxyurea—brain cancer	0.000301	0.00221	CcSEcCtD
Sulfamethoxazole—Chills—Etoposide—brain cancer	0.0003	0.0022	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Temozolomide—brain cancer	0.000297	0.00218	CcSEcCtD
Sulfamethoxazole—Anorexia—Carmustine—brain cancer	0.000293	0.00215	CcSEcCtD
Sulfamethoxazole—UGT1A9—Irinotecan Pathway—APC—brain cancer	0.000293	0.0199	CbGpPWpGaD
Sulfamethoxazole—Nausea—Procarbazine—brain cancer	0.000292	0.00214	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Temozolomide—brain cancer	0.000291	0.00214	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Temozolomide—brain cancer	0.000291	0.00213	CcSEcCtD
Sulfamethoxazole—Skin disorder—Temozolomide—brain cancer	0.000289	0.00212	CcSEcCtD
Sulfamethoxazole—Anorexia—Temozolomide—brain cancer	0.000283	0.00208	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Hydroxyurea—brain cancer	0.00028	0.00206	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Carmustine—brain cancer	0.00028	0.00206	CcSEcCtD
Sulfamethoxazole—Insomnia—Carmustine—brain cancer	0.000278	0.00204	CcSEcCtD
Sulfamethoxazole—PTGS1—central nervous system—brain cancer	0.000276	0.00638	CbGeAlD
Sulfamethoxazole—Dyspnoea—Carmustine—brain cancer	0.000274	0.00201	CcSEcCtD
Sulfamethoxazole—Asthenia—Hydroxyurea—brain cancer	0.000273	0.002	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000271	0.00199	CcSEcCtD
Sulfamethoxazole—CYP2C8—brain—brain cancer	0.00027	0.00625	CbGeAlD
Sulfamethoxazole—Insomnia—Temozolomide—brain cancer	0.000269	0.00197	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Carmustine—brain cancer	0.000267	0.00196	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Carmustine—brain cancer	0.000265	0.00195	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Temozolomide—brain cancer	0.000265	0.00194	CcSEcCtD
Sulfamethoxazole—Vertigo—Etoposide—brain cancer	0.000262	0.00192	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Temozolomide—brain cancer	0.000261	0.00192	CcSEcCtD
Sulfamethoxazole—Leukopenia—Etoposide—brain cancer	0.000261	0.00191	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Hydroxyurea—brain cancer	0.00026	0.00191	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Temozolomide—brain cancer	0.000258	0.00189	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Temozolomide—brain cancer	0.000256	0.00188	CcSEcCtD
Sulfamethoxazole—Fatigue—Temozolomide—brain cancer	0.000256	0.00188	CcSEcCtD
Sulfamethoxazole—CYP3A4—endocrine gland—brain cancer	0.000256	0.00591	CbGeAlD
Sulfamethoxazole—Cough—Etoposide—brain cancer	0.000254	0.00187	CcSEcCtD
Sulfamethoxazole—Convulsion—Etoposide—brain cancer	0.000252	0.00185	CcSEcCtD
Sulfamethoxazole—Dizziness—Hydroxyurea—brain cancer	0.000251	0.00185	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Carmustine—brain cancer	0.000251	0.00184	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000246	0.00181	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Carmustine—brain cancer	0.000243	0.00178	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Carmustine—brain cancer	0.000243	0.00178	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Temozolomide—brain cancer	0.000243	0.00178	CcSEcCtD
Sulfamethoxazole—Vomiting—Hydroxyurea—brain cancer	0.000242	0.00177	CcSEcCtD
Sulfamethoxazole—Rash—Hydroxyurea—brain cancer	0.00024	0.00176	CcSEcCtD
Sulfamethoxazole—Dermatitis—Hydroxyurea—brain cancer	0.00024	0.00176	CcSEcCtD
Sulfamethoxazole—Headache—Hydroxyurea—brain cancer	0.000238	0.00175	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Etoposide—brain cancer	0.000238	0.00174	CcSEcCtD
Sulfamethoxazole—Urticaria—Temozolomide—brain cancer	0.000236	0.00173	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Temozolomide—brain cancer	0.000235	0.00172	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Temozolomide—brain cancer	0.000235	0.00172	CcSEcCtD
Sulfamethoxazole—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000235	0.0159	CbGpPWpGaD
Sulfamethoxazole—Thrombocytopenia—Etoposide—brain cancer	0.000233	0.00171	CcSEcCtD
Sulfamethoxazole—Skin disorder—Etoposide—brain cancer	0.000231	0.00169	CcSEcCtD
Sulfamethoxazole—CYP3A4—central nervous system—brain cancer	0.00023	0.00533	CbGeAlD
Sulfamethoxazole—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000228	0.0155	CbGpPWpGaD
Sulfamethoxazole—Anorexia—Etoposide—brain cancer	0.000227	0.00166	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Carmustine—brain cancer	0.000226	0.00166	CcSEcCtD
Sulfamethoxazole—Nausea—Hydroxyurea—brain cancer	0.000226	0.00166	CcSEcCtD
Sulfamethoxazole—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000226	0.0153	CbGpPWpGaD
Sulfamethoxazole—Asthenia—Carmustine—brain cancer	0.000221	0.00162	CcSEcCtD
Sulfamethoxazole—PTGS1—brain—brain cancer	0.000219	0.00506	CbGeAlD
Sulfamethoxazole—Hypersensitivity—Temozolomide—brain cancer	0.000219	0.00161	CcSEcCtD
Sulfamethoxazole—Asthenia—Temozolomide—brain cancer	0.000213	0.00156	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Etoposide—brain cancer	0.000212	0.00156	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Carmustine—brain cancer	0.00021	0.00154	CcSEcCtD
Sulfamethoxazole—Pruritus—Temozolomide—brain cancer	0.00021	0.00154	CcSEcCtD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00021	0.0143	CbGpPWpGaD
Sulfamethoxazole—Decreased appetite—Etoposide—brain cancer	0.000207	0.00152	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Etoposide—brain cancer	0.000205	0.00151	CcSEcCtD
Sulfamethoxazole—Fatigue—Etoposide—brain cancer	0.000205	0.0015	CcSEcCtD
Sulfamethoxazole—Dizziness—Carmustine—brain cancer	0.000203	0.00149	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Temozolomide—brain cancer	0.000203	0.00149	CcSEcCtD
Sulfamethoxazole—Dizziness—Temozolomide—brain cancer	0.000196	0.00144	CcSEcCtD
Sulfamethoxazole—Vomiting—Carmustine—brain cancer	0.000195	0.00143	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Etoposide—brain cancer	0.000194	0.00143	CcSEcCtD
Sulfamethoxazole—Rash—Carmustine—brain cancer	0.000194	0.00142	CcSEcCtD
Sulfamethoxazole—Dermatitis—Carmustine—brain cancer	0.000194	0.00142	CcSEcCtD
Sulfamethoxazole—Headache—Carmustine—brain cancer	0.000193	0.00141	CcSEcCtD
Sulfamethoxazole—UGT1A9—PPAR Alpha Pathway—CDK4—brain cancer	0.000189	0.0129	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Temozolomide—brain cancer	0.000189	0.00139	CcSEcCtD
Sulfamethoxazole—Urticaria—Etoposide—brain cancer	0.000189	0.00139	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Etoposide—brain cancer	0.000188	0.00138	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Etoposide—brain cancer	0.000188	0.00138	CcSEcCtD
Sulfamethoxazole—Rash—Temozolomide—brain cancer	0.000187	0.00137	CcSEcCtD
Sulfamethoxazole—Dermatitis—Temozolomide—brain cancer	0.000187	0.00137	CcSEcCtD
Sulfamethoxazole—Headache—Temozolomide—brain cancer	0.000186	0.00137	CcSEcCtD
Sulfamethoxazole—Nausea—Carmustine—brain cancer	0.000183	0.00134	CcSEcCtD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000181	0.0123	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000179	0.0122	CbGpPWpGaD
Sulfamethoxazole—Nausea—Temozolomide—brain cancer	0.000176	0.00129	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—CYP2C9—brain cancer	0.000176	0.0119	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Etoposide—brain cancer	0.000175	0.00129	CcSEcCtD
Sulfamethoxazole—Asthenia—Etoposide—brain cancer	0.000171	0.00125	CcSEcCtD
Sulfamethoxazole—Pruritus—Etoposide—brain cancer	0.000168	0.00123	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Etoposide—brain cancer	0.000163	0.00119	CcSEcCtD
Sulfamethoxazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000161	0.0109	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Etoposide—brain cancer	0.000157	0.00115	CcSEcCtD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000153	0.0104	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000153	0.0104	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Etoposide—brain cancer	0.000151	0.00111	CcSEcCtD
Sulfamethoxazole—Rash—Etoposide—brain cancer	0.00015	0.0011	CcSEcCtD
Sulfamethoxazole—Dermatitis—Etoposide—brain cancer	0.00015	0.0011	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—BSG—brain cancer	0.000149	0.0101	CbGpPWpGaD
Sulfamethoxazole—Headache—Etoposide—brain cancer	0.000149	0.00109	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP2C9—brain cancer	0.000148	0.0101	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000147	0.01	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	0.000146	0.00995	CbGpPWpGaD
Sulfamethoxazole—Nausea—Etoposide—brain cancer	0.000141	0.00104	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—IDH1—brain cancer	0.000128	0.00873	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	0.000122	0.00831	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000121	0.00822	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—ENO2—brain cancer	0.000101	0.0069	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	9.81e-05	0.00667	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	9.74e-05	0.00662	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	9.61e-05	0.00653	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Irinotecan Pathway—APC—brain cancer	8.27e-05	0.00562	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	8e-05	0.00544	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	7.95e-05	0.0054	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.89e-05	0.00537	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP2C9—brain cancer	7.81e-05	0.00531	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	7.71e-05	0.00524	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	7.41e-05	0.00504	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	7.36e-05	0.005	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	7.34e-05	0.00499	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP2C9—brain cancer	7.29e-05	0.00496	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—BSG—brain cancer	6.2e-05	0.00421	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	6.08e-05	0.00413	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—SOD2—brain cancer	5.99e-05	0.00407	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.7e-05	0.00387	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—IDH1—brain cancer	5.33e-05	0.00362	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—SOD2—brain cancer	4.76e-05	0.00323	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CG—brain cancer	4.66e-05	0.00316	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.64e-05	0.00316	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	4.28e-05	0.00291	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—RELA—brain cancer	4.26e-05	0.00289	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ENO2—brain cancer	4.21e-05	0.00286	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.19e-05	0.00285	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.17e-05	0.00283	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.14e-05	0.00281	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MPL—brain cancer	4.12e-05	0.0028	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—S100A10—brain cancer	3.95e-05	0.00269	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	3.54e-05	0.00241	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—RELA—brain cancer	3.46e-05	0.00235	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	3.42e-05	0.00233	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.4e-05	0.00231	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL2—brain cancer	3.12e-05	0.00212	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3e-05	0.00204	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.98e-05	0.00203	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—BSG—brain cancer	2.79e-05	0.00189	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—RELA—brain cancer	2.75e-05	0.00187	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	2.65e-05	0.0018	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP2C9—brain cancer	2.54e-05	0.00172	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—brain cancer	2.27e-05	0.00154	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.19e-05	0.00149	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.18e-05	0.00148	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	2.16e-05	0.00147	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—BSG—brain cancer	2.16e-05	0.00147	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP2C9—brain cancer	2.07e-05	0.00141	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—brain cancer	2e-05	0.00136	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CG—brain cancer	1.93e-05	0.00131	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—IDH1—brain cancer	1.86e-05	0.00126	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TRPC6—brain cancer	1.83e-05	0.00124	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.79e-05	0.00121	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—BSG—brain cancer	1.76e-05	0.0012	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.69e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	1.58e-05	0.00107	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—IDH1—brain cancer	1.51e-05	0.00103	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.51e-05	0.00103	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ENO2—brain cancer	1.47e-05	0.000997	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VAV1—brain cancer	1.37e-05	0.00093	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2C9—brain cancer	1.34e-05	0.000908	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2C9—brain cancer	1.33e-05	0.000903	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.23e-05	0.000837	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ENO2—brain cancer	1.2e-05	0.000812	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.19e-05	0.000806	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BSG—brain cancer	1.14e-05	0.000772	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BSG—brain cancer	1.13e-05	0.000768	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.01e-05	0.000685	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—IDH1—brain cancer	9.77e-06	0.000664	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—IDH1—brain cancer	9.71e-06	0.00066	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BSG—brain cancer	9.25e-06	0.000628	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CG—brain cancer	8.69e-06	0.00059	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.95e-06	0.000541	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—IDH1—brain cancer	7.95e-06	0.00054	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.91e-06	0.000538	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ENO2—brain cancer	7.72e-06	0.000525	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ENO2—brain cancer	7.68e-06	0.000522	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2C9—brain cancer	7.17e-06	0.000487	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CG—brain cancer	6.73e-06	0.000457	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.47e-06	0.00044	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ENO2—brain cancer	6.28e-06	0.000427	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—brain cancer	6.11e-06	0.000415	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BSG—brain cancer	6.1e-06	0.000414	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CG—brain cancer	5.48e-06	0.000373	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—IDH1—brain cancer	5.24e-06	0.000356	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—brain cancer	5.2e-06	0.000353	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ENO2—brain cancer	4.14e-06	0.000282	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—brain cancer	3.93e-06	0.000267	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CG—brain cancer	3.54e-06	0.000241	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CG—brain cancer	3.52e-06	0.000239	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CG—brain cancer	2.88e-06	0.000196	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CG—brain cancer	1.9e-06	0.000129	CbGpPWpGaD
